Sanbio Co Ltd. receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
SymBio Pharmaceuticals Ltd (4582)
SymBio Pharmaceuticals Ltd stock price live, this page displays TYO 4582 stock exchange data. View the 4582 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the SymBio Pharmaceuticals Ltd real time stock price chart below.
What Is the SymBio Pharmaceuticals Ltd Stock Price Today?
The SymBio Pharmaceuticals Ltd stock price today is 156.0.
What Is the Stock Symbol for SymBio Pharmaceuticals Ltd?
The stock symbol for SymBio Pharmaceuticals Ltd is ""4582.""
What Stock Exchange Does SymBio Pharmaceuticals Ltd Trade On?
SymBio Pharmaceuticals Ltd is listed and trades on the Tokyo stock exchange.
Is SymBio Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether SymBio Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4582 quote. (ISIN: JP3383050006)
What Is the SymBio Pharmaceuticals Ltd Stock Price Today?
The SymBio Pharmaceuticals Ltd stock price today is 156.0.
What Is the Stock Symbol for SymBio Pharmaceuticals Ltd?
The stock symbol for SymBio Pharmaceuticals Ltd is ""4582.""
What Stock Exchange Does SymBio Pharmaceuticals Ltd Trade On?
SymBio Pharmaceuticals Ltd is listed and trades on the Tokyo stock exchange.
Is SymBio Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether SymBio Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4582 quote. (ISIN: JP3383050006)
Tokyo
Currency in JPY
156.0
-2.0(-1.27%)
Closed·
Fair Value
An estimate of a SymBio Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
156.0
164.0
52 wk Range
126.0
329.0
4582 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
4582 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a SymBio Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
156.0164.0
52 wk Range
126.0329.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4582 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a SymBio Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
SymBio Pharmaceuticals Ltd Company Profile
SymBio Pharmaceuticals Limited engages in the research and development, manufacturing, and sales of pharmaceuticals and related operations to treat cancer, hematology, and viral infectious diseases in Japan and internationally. It offers SyB L-0501, an anti-cancer agent for the treatment of non-Hodgkin's lymphoma, multiple myeloma, chronic lymphocytic leukemia, and relapsed/refractory diffuse large B-cell lymphoma; SyB L-1701, a ready-to-dilute formulation; and SyB L-1702, a rapid infusion liquid administration under the TREAKISYM name. The company also engages in the development of SyB L-1101, an intravenous formulation, which completed Phase III clinical trial for the treatment of higher-risk myelodysplastic syndromes (HR-MDS); and SyB C-1101, an oral formulation that is in Phase II clinical trial in combination with AZA to treat HR-MDS. In addition, it is involved in the development SyB V-1901, an antiviral drug. SymBio Pharmaceuticals Limited was incorporated in 2005 and is based in Tokyo, Japan.
Compare 4582 to Peers and Sector
Metrics to compare | 4582 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4582PeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.6x | 12.7x | −0.5x | |
PEG Ratio | 0.07 | 0.18 | 0.00 | |
Price/Book | 3.2x | 1.4x | 2.6x | |
Price / LTM Sales | 4.2x | 2.0x | 3.3x | |
Upside (Analyst Target) | - | −1.7% | 43.3% | |
Fair Value Upside | Unlock | 1.8% | 6.9% | Unlock |
Earnings
Latest Release
Jul 31, 2025
EPS / Forecast
-21.49 / --
Revenue / Forecast
381.98M / --
FAQ
What Stock Exchange Does SymBio Pharmaceuticals Trade On?
SymBio Pharmaceuticals is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for SymBio Pharmaceuticals?
The stock symbol for SymBio Pharmaceuticals is "4582."
What Is the SymBio Pharmaceuticals Market Cap?
As of today, SymBio Pharmaceuticals market cap is 7.60B.
What Is SymBio Pharmaceuticals's Earnings Per Share (TTM)?
The SymBio Pharmaceuticals EPS (TTM) is -99.35.
When Is the Next SymBio Pharmaceuticals Earnings Date?
SymBio Pharmaceuticals will release its next earnings report on 29 Oct 2025.
From a Technical Analysis Perspective, Is 4582 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has SymBio Pharmaceuticals Stock Split?
SymBio Pharmaceuticals has split 1 times.
How Many Employees Does SymBio Pharmaceuticals Have?
SymBio Pharmaceuticals has 108 employees.
What is the current trading status of SymBio Pharmaceuticals (4582)?
As of 11 Aug 2025, SymBio Pharmaceuticals (4582) is trading at a price of 156.00, with a previous close of 158.00. The stock has fluctuated within a day range of 156.00 to 164.00, while its 52-week range spans from 126.00 to 329.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.